SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about disclosure on related party transactions

26 May 2022 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it enclosed the disclosure on Related Party Transactions, on a consolidated basis, prepared in accordance with the applicable accounting standards for the half year ended March 31, 2022. This disclosure will also be made available on the website of the Company and can be accessed using the link http://www.orchidpharma.com/invr_intimation.aspx.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

565.60 12.75 (2.31%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×